Key Record Dates
ClinicalTrials.gov Identifier: | NCT04040725 |
---|---|
Brief Title: | Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression |
First Submitted : | July 30, 2019 |
First Submitted that Met QC Criteria : | July 30, 2019 |
First Posted : | August 1, 2019 |
Last Update Submitted that Met QC Criteria : | December 13, 2019 |
Last Update Posted : | December 17, 2019 |